AU2003288127A1 - DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE - Google Patents

DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE

Info

Publication number
AU2003288127A1
AU2003288127A1 AU2003288127A AU2003288127A AU2003288127A1 AU 2003288127 A1 AU2003288127 A1 AU 2003288127A1 AU 2003288127 A AU2003288127 A AU 2003288127A AU 2003288127 A AU2003288127 A AU 2003288127A AU 2003288127 A1 AU2003288127 A1 AU 2003288127A1
Authority
AU
Australia
Prior art keywords
diagnostic
therapeutic use
alzheimer disease
rev107 protein
rev107
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003288127A
Inventor
Johannes Pohlner
Heinz Von Der Kammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evotec Neurosciences GmbH
Original Assignee
Evotec Neurosciences GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evotec Neurosciences GmbH filed Critical Evotec Neurosciences GmbH
Publication of AU2003288127A1 publication Critical patent/AU2003288127A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003288127A 2002-11-27 2003-11-20 DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE Abandoned AU2003288127A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42931102P 2002-11-27 2002-11-27
US60/429,311 2002-11-27
EP02026506 2002-11-27
EP02026506.2 2002-11-27
PCT/EP2003/012997 WO2004048979A1 (en) 2002-11-27 2003-11-20 DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE

Publications (1)

Publication Number Publication Date
AU2003288127A1 true AU2003288127A1 (en) 2004-06-18

Family

ID=56290505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003288127A Abandoned AU2003288127A1 (en) 2002-11-27 2003-11-20 DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE

Country Status (3)

Country Link
EP (1) EP1565751A1 (en)
AU (1) AU2003288127A1 (en)
WO (1) WO2004048979A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103030688B (en) * 2011-09-30 2014-09-17 北京大学 Short chain polypeptide for inhibiting cancer cell growth as well as encoding gene and application of short chain polypeptide
KR102222693B1 (en) * 2019-04-04 2021-03-04 금정제약 주식회사 Novel uses of H-REV107 derived peptide
KR102488353B1 (en) * 2020-10-08 2023-01-12 부산대학교 산학협력단 Peptides targeting mutant KRAS and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN649395A0 (en) * 1995-11-10 1995-12-07 Ramsay Health Care Pty Ltd A method for diagnosing alzheimer's disease
US6359123B1 (en) * 1997-02-14 2002-03-19 Incyte Genomics, Inc. H-rev107-like protein

Also Published As

Publication number Publication date
WO2004048979A1 (en) 2004-06-10
EP1565751A1 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
EP1578421A4 (en) Pharmaceutical preparations for treatments of diseases and disorders of the breast
AU2002327792A1 (en) Diagnosis and treatment of diseases caused by mutations in cd72
AU2003261073A1 (en) Combined diagnostic and therapeutic ultrasound system
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU2003267532A1 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU2003246380A1 (en) Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003260301A1 (en) Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
AU2003278497A1 (en) Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases
AU2003279312A1 (en) Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases
AU2003288127A1 (en) DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE
AU2003224080A1 (en) Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases
AU2003242588A1 (en) Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases
AU2003222849A1 (en) Diagnostic and therapeutic use of ensadin-0255 gene and protein for neurodegenerative diseases
AU2003289859A1 (en) Diagnostic and therapeutic use of arl7 for alzheimer's disease
AU2003251709A1 (en) Diagnostic and therapeutic use of proteolipid protein for alzheimer's disease
AU2003224095A1 (en) Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
AU2003265867A1 (en) A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
AU2003235665A1 (en) Diagnostic and therapeutic uses of topors
AU2003260460A1 (en) Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
AU2003222842A1 (en) Diagnostic and therapeutic use of ensadin-0138 gene and protein for neurodegenerative diseases
AU2003294696A1 (en) Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
AU2003297570A1 (en) Treatment of skin diseases
AU2003263036A1 (en) SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase